SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-010821
Filing Date
2018-02-16
Accepted
2018-02-16 16:13:50
Documents
2
Period of Report
2018-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4092
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4273
  Complete submission text file 0001209191-18-010821.txt   9784
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Santillana Sergio L. (Reporting) CIK: 0001708767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 18621341